A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cerebrovascular disease may cause "vascular depression" (VaD). Calcium channel-blockers are presumed treatments for cerebrovascular disease and might be expected to improve depression and prevent recurrence. OBJECTIVE: To examine the efficacy and tolerability of the use of nimodipine as an augmentation of fluoxetine in the treatment of VaD. DESIGN: A double-blind, randomized clinical trial in which 101 patients with VaD (Alexopoulos criteria) were treated with fluoxetine at standard doses. Patients were randomized to placebo (n=51) or nimodipine (n=50). Treatment outcomes were assessed using the Hamilton Depression Rating Scale (HDRS) regularly up to 8 months after treatment initiation. RESULTS: Depression was reduced in 63% of patients, but those whose treatment was enhanced with nimodipine had greater improvements overall by repeated measures analysis of covariance (ANCOVA) (F(1.80) = 9.76, p=0.001). In addition, a greater proportion of patients treated with fluoxetine-nimodipine (54% vs. 27%) exhibited full remission (chi2(d.f. 1)= 7.3, p = 0.006), with the number needed to treat (NNT) equal to 4 (95% CI 2-12). Of those experiencing full remission in the first 61 days, fewer patients on fluoxetine-nimodipine (3.7%) developed recurrence of major depression as compared to those on fluoxetine alone (35.7%) (chi2(d.f. 1) = 7.56, p = 0.006), NNT 3 (95% CI 2-9). Side-effects were noted in 33.3% of patients in the control group and 48% of the experimental group (chi2(d.f. 1) = 2.25, p = 0.133). CONCLUSIONS: In treating VaD, augmentation of fluoxetine with nimodipine led to better treatment results and lower rates of recurrence. These findings support the argument that augmentation of antidepressant therapy might be helpful in the treatment of cerebrovascular disease, which is involved in the pathogenesis of this type of depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, a greater proportion of patients treated with fluoxetine–nimodipine (54 vs. 27%) achieved remission, with the number needed to treat (NNT) equal to 4 (95% CI: 2–12).”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [193]
In the citing paper
“Of those experiencing full remission in the first 61 days, fewer patients on fluoxetine plus nimodipine (3.7%) developed recurrence of major depression as compared to those on fluoxetine alone (35.7%), NNT 3 (95% CI 2–9).”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [193]
In the citing paper
“In a follow-up study of patients with vascular depression treated with fluoxetine, augmentation with nimodipine reduced depressive symptoms more than addition of placebo193.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [193]
Citations
Cites
'Vascular Depression' Hypothesis
Alexopoulos, G. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220033006 · Cited by 1,843 · cited 2×
“Alexopoulos et al. (1997) have illustrated the clinical syndrome of VaD that occurs in later life, and its association with mild cognitive disturbance.”
BackgroundIschemic Basis for Deep White Matter Hyperintensities in Major Depression: A Neuropathological Study
Thomas, A. J., O'Brien, J. T., Davis, S., Ballard, C., Barber, R., Kalaria, R. N., & Perry, R. H. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.785 · Cited by 365
White Matter Hyperintensity Progression and Late-Life Depression Outcomes
Taylor, W. D., Steffens, D. C., MacFall, J. R., McQuoid, D. R., Payne, M. E., Provenzale, J. M., & Krishnan, K. R. R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1090 · Cited by 237
Cerebrovascular Disease and Evolution of Depressive Symptoms in the Cardiovascular Health Study
Steffens, D. C., Krishnan, K. R. R., Crump, C., & Burke, G. L. (2002) · Stroke · doi:10.1161/01.str.0000018405.59799.d5 · Cited by 221
Vascular basis of late-onset depressive disorder
Baldwin, R. C., & O'Brien, J. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.2.157 · Cited by 168
Late‐Life Depression is Associated with Arterial Stiffness: A Population‐Based Study
Tiemeier, H. W., Breteler, M. M. B., van Popele, N. M., Hofman, A., & Witteman, J. C. M. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51359.x · Cited by 105
Taragano, F. E., Allegri, R., Vicario, A., Bagnatti, P., & Lyketsos, C. G. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.340 · Cited by 103 · cited 2×
“A randomized, controlled study by Taragano et al. (2001) showed that VaD is probably pathophysiologically linked to cerebrovascular disease, as a consequence of using nimodipine to augment the standard antidepressant treatment was an improvement in the course of depression and a decrease in the…”
BackgroundSelf-citationA neuropathological study of vascular factors in late-life depression
Thomas, A. J. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.1.83 · Cited by 96
Pantoni, L., Rossi, R., Inzitari, D., Bianchi, C., Beneke, M., Erkinjuntti, T., & Wallin, A. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00300-2 · Cited by 92
Mast, B. T., Neufeld, S. W., MacNeill, S. E., & Lichtenberg, P. A. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200401000-00012 · Cited by 71
Research works printed but not linked: 3
- Ketter, 2002, Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies, Journal of Clinical Psychiatry, 63, 21
- Lopez-Arrieta, J. M. and Birks, J. (2004). Nimodipine for primary degenerative, mixed and vascular dementia (Cochrane Review). In The Cochrane Library, Issue 2. Chichester, U.K.: John Wiley & Sons, Ltd.
- Rinkel, 2003, Calcium antagonists for aneurysmal subarachnoid hemorrhage (Cochrane Review), Issue 3
Cited by
Mechanisms and treatment of late-life depression
Alexopoulos, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0514-6 · Cited by 592
Interventions for treating depression after stroke
Hackett, M. L., Anderson, C. S., House, A., & Xia, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003437.pub3 · Cited by 387
CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease
Bhat, S., Dao, D. T., Terrillion, C. E., Arad, M., Smith, R. J., Soldatov, N. M., & Gould, T. D. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.001 · Cited by 271
Naismith, S. L., Norrie, L. M., Mowszowski, L., & Hickie, I. B. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.009 · Cited by 270
Interventions for preventing depression after stroke
Hackett, M. L., Anderson, C. S., House, A., & Halteh, C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003689.pub3 · Cited by 264
Metadata
- Authors
- Taragano, F. E., Bagnatti, P., & Allegri, R. F.
- Affiliations
- Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (AR)
- ORCID
- Allegri, R.F.
- Venue
- International Psychogeriatrics
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 17
- Issue
- 3
- Pages
- 487-498
- ISSN
- 1041-6102 (ISSN-L)
- OpenAlex
- W2218138696
- Cited by
- 90
- References
- 19
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 7 · 2016: 1 · 2015: 1 · 2014: 4 · 2013: 5 · 2012: 6
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 7060 d)
- Locations
- International Psychogeriatrics (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- vascular depression, nimodipine, fluoxetine, antidepressant augmentation, calcium channel blockers, cerebrovascular disease, depression recurrence, remission, adverse effects
- MeSH terms
- Aged, Argentina, Calcium Channel Blockers, Cerebrovascular Disorders, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Drug Synergism, Drug Therapy, Combination, Female, Fluoxetine, Humans, Male, Middle Aged, Nimodipine, Outcome Assessment, Health Care, Antidepressive Agents, Second-Generation, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”. https://app.cochat.ai/papers/10.1017/s1041610205001493
- The paper
- Taragano, F. E., Bagnatti, P., & Allegri, R. F. (2005). A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”. International Psychogeriatrics. https://doi.org/10.1017/s1041610205001493
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.